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RNA methylation, which is a form of posttranscriptional modiﬁcation, is catalyzed by S-adenosyl-L-methionone-dependent
RNA methyltransterases (RNA MTases). We have identiﬁed a novel silkworm gene, BmRNAMTase, containing a 369-bp open
reading frame that encodes a putative protein containing 122 amino acid residues and having a molecular weight of 13.88 kd.
We expressed a recombinant His-tagged BmRNAMTase in E. coli BL21 (DE3), puriﬁed the fusion protein by metal-chelation
aﬃnity chromatography, and injected a New Zealand rabbit with the puriﬁed protein to generate anti-BmRNAMTase polyclonal
antibodies. Immunohistochemistry revealed that BmRNAMTase is abundant in the cytoplasm of Bm5 cells. In addition, using
RNA interference to reduce the intracellular activity and content of BmRNAMTase, we determined that this cytoplasmic RNA
methyltransferase may be involved in preventing cell death in the silkworm.
Copyright © 2008 Zuoming Nie et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
S-adenosyl-L-methionone-dependent RNA methyltrans-
ferases (RNA MTases) are enzymes that use S-adenosyl-
L-methionone (AdoMet) as the methyl donor group
when catalyzing the methylation of RNA substrates [1–3].
Methylation of RNAs may modulate RNA maturation, alter
RNA structure stability, and aﬀect translation rates [4].
Several studies have indicated that almost all MTases have
similar basic structures, however, the substrates targeted by
various Mtases diﬀer because of small diﬀerences in regions
of the enzymes that contain the substrate binding site
[5, 6]. The catalytic domain of MTases is highly conserved,
including the common structural core and the AdoMet
binding site, which accommodates the catalytic reaction and
releases the ﬁnal catalyzed product. The catalytic domain
also plays an important role in stabilizing the conformation
of the enzyme [7].
Due to variations in the binding sites for AdoMet, the
binding methyl groups are allocated to diﬀerent substrates;
accordingly, AdoMet-dependent MTases are divided into ﬁve
families (Class I–Class V) [8]. BmRNAMtase, which was
derived from a Bombyx mori pupae stage cDNA library
constructed in our laboratory, belongs to Class IV, otherwise
known as the SPOUT (SpoU-TrmD) family of RNA MTases
[9, 10]. The SpoU and TrmD families were previously
considered to be independent families, however, amino acid
sequenceanalyseshaveshownthatmembersofthesefamilies
share three common sequence motifs and also contain a
“deep trefoil knot” motif in the C-terminus. Sequence analy-
sesalsoindicatethatmatureSpoUproteinscanpotentiallybe
targeted for several types of posttranslational modiﬁcations
including N-myristoylation, cAMP- and cGMP-dependent
protein kinase phosphorylation, and glycosylation.
In this study, we performed bioinformatics analysis
of BmRNAMTase and expressed the BmRNAMTase open
reading frame in E. coli BL21 (DE3). Rabbits inoculated
with the recombinant protein generated high titer polyclonal
antibodies, which we used to determine the subcellular
localization of BmRNAMTase in a Bombyx mori cell line by
confocal immunoﬂuorescence microscopy. Finally, we also
investigated the eﬀect of BmRNAMTase dsRNA on Bm5 cell
growthanddeterminedthatsilencingBmRNAMTaseactivity
resulted in increased cell death but did not induce apoptosis.2 Comparative and Functional Genomics
Table 1: The primers used in the experiments.
Name Sequences The instead of underline Function
P1 5 -GGAGCTCATGCCTGAACATCAAG-3 SacI Amplifying the fragment of BmRNAMTase
P2 5 -GGTCGACTTATGTGTTAAGTTCTG-3  SalI
P3
5 -GGATCCTAATACGACTCACTATAGA
TGCCTGAACATACAAGA-3  T7 promoter Synthesizing the dsRNA of BmRNAMTase
P4
5 -GGATCCTAATACGACTCACTATAGT
TATGTGTTAAGTTCTGC-3  T7 promoter
2.MaterialsandMethods
2.1. The BioinformaticAnalysisof
BmRNAMTase
The similarity analysis of nucleotide and protein sequences
was carried out using the BLASTN and BLASTP algorithms
(NCBI). The deduced amino acid sequence and characteris-
ticsofBmRNAMTasewereanalyzedusingtheExpert Protein
Analysis System (http://www.expasy.org/). The phylogenetic
tree for BmRNAMTase and additional RNA methylases was
generated using the MEGA 3.1 software.
2.2. Constructionof RecombinantPlasmid
To amplify the open reading frame of BmRNAMTase from
the cDNA fragment in a silkworm pupa cDNA library
constructed by our laboratory [11], we performed the
polymerase chain reaction (PCR) using upstream oligonu-
cleotide primer P1 and downstream oligonucleotide primer
P2 (Table 1). We digested the PCR product with SacIa n d
SalI (Promega , Madison, USA) and ligated it into SacI-S a lI-
digested pET-28a(+) expression vector. The recombinant
plasmid was transformed into E. coli BL21 (DE3).
2.3. ExpressionandPurificationof
RecombinantProtein
The transformed strain was grown at 37
oC in Luria-Bertani
medium containing kanamycin (100μg/μl) until the optical
density at 600 nm of the culture reached 0.6. Isopropyl-1-
thio-β-D-galactopyranoside (IPTG) (Promega) was added
to the culture to a ﬁnal concentration of 1mM, and cells
were grown for an additional 5 hours before harvesting.
The cells were pelleted by centrifugation; the cell pellet was
suspended in phosphate-buﬀered saline (PBS), and the cells
werelysedbysonication.Thelysedcellswerecentrifugedand
the supernatant was loaded onto an SP-Sepharose (G200)
column; fractions collected from the Sepharose column that
contained the recombinant protein were loaded onto an
Ni2+-SephadexTM G-25 Superﬁne (HiTrapTM) desalting
column (Amersham, Piscataway, USA) [12]. Puriﬁed BmR-
NAMTase was analyzed by SDS-PAGE.
2.4. Preparationof Polyclonal Antibodies and
WesternBlot Analysis
Rabbits inoculated with puriﬁed recombinant protein gen-
erated high titer anti-BmRNAMTase polyclonal antibodies,
as determined by ELISA [12]. We determined the speciﬁcity
of the polyclonal antibodies for recombinant BmRNAMTase
and for BmRNAMTase in silkworm pupae by Western blot
analysis [12].
2.5. SubcellularLocalizationof BmRNAMTase
Bm5 cells were seeded into a dish for confocal microscopy.
Cells were rinsed twice with 1mL PBS, ﬁxed in 3.7%
formaldehyde at 25
oC for 25 minutes, and rinsed three
additional times with PBS. The ﬁxed cells were blocked in
a3 %B S As o l u t i o na t2 5
oC for 2 hours. The cells were
then incubated with anti-BmRNAMTase serum (dilution,
1:50) at 4
oC for 12 hours. After three 10-minute washes
with PBST (PBS+0.05% Tween-20), the cells were incu-
bated with Cy3-labelled goat antirabbit antibody (dilution,
1:2000) (Promega) at 37
oCf o r2h o u r s ,a n dﬁ n a l l yc e l l s
wereincubatedwith4 -6-Diamidino-2-phenylindole(DAPI)
(dilution, 1:2000) (Promega) at room temperature for 10
minutes. Following two 10-minute washes with PBST and
another two 10-minute washes with PBS, cells were observed
under a Nikon ECLIPSE TE2000-E confocal microscope and
images were analyzed using EZ-C1 software.
2.6. RNAi
To determine BmRNAMTase function, we transfected Bm5
cells with a BmRNAMTase dsRNA. The BmRNAMTase ORF
wasampliﬁedbyPCRusingprimerscontainingT7promoter
sequences (P3 and P4) (Table 1). The primer used for the
sensestrandwasP3andfortheantisensestrandwasP4.pET-
28a(+)-BmRNAMTase was used as the template for the PCR,
and we ampliﬁed the two single strands using two primer
pairs: P3 and P2, and P4 and P1 (Table 1). Using the T7
RiboMAXExpress RNAi System kit (Promega), we synthe-
sized the dsRNA and puriﬁed PCR products according to the
manufacturer’s instructions. The products were quantiﬁed
spectrophotometrically at 260nm and conﬁrmed by agarose
gel electrophoresis. Silkworm Bm5 cells were transfected
withtheBmRNAMTasedsRNAusingliposomes(Invitrogen,Comparative and Functional Genomics 3
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Figure 1: Bioinformatics analysis of the silkworm BmRNAMTase gene. (a) A schematic representation of the silkworm BmRNAMTase gene;
this gene contains two exons. (b) Homologous alignment between deduced amino acid sequences of BmRNAMTase and proteins derived
from other species. The asterisks indicate the identical amino acids; the black areas indicate the conserved domains of SpoU-methylase and
SpoU. I, II, III represent conserved motifs, respectively.
Carlsbad, USA), and cytoactivity was determined after
treatment with diﬀerent concentrations of dsRNA (1.2, 2.4,
3.6, 4.8, 6.0, 7.2, and 8.4 μg/μl) and the eﬀectiveness of
diﬀerent durations of the RNAi treatment (12, 24, 36, 48,
60, 72, 84, and 96 hours) was determined using MTT [13].
Using a cell counter, we determined when the cell density
reached about 1 × 105 units/mL after the RNAi treatment.
At that time, we extracted the total protein from the cells
and determined the change in BmRNAMTase content in the
cells caused by the RNAi treatement using ELISAs. The eﬀect
of the treatment on cell growth and death was determined
by examining the chromosomal DNA; the appearance of a
characteristic DNA ladder signiﬁes cell apoptosis [13].
3.Results
3.1. BioinformaticAnalysisof
BmRNAMTase Sequence
We obtained a unique cDNA containing a 369bp open
reading frame that encodes an AdoMet-dependent RNA
methyltransferase protein containing 122 amino acid and
having a predicted molecular weight of 13.88kd from a
silkworm pupae cDNA library constructed in our laboratory
(GenBank accession number DQ813500). This gene, BmR-
NAMTase, contains two exons and one intron (Figure 1(a))
and encodes an RNA methyltransferase that contains a
domain that is highly conserved (SpoU) in similar genes
in other species (Figure 1(b)). We have determined that
BmRNAMTase is the ﬁrst reported Bombyx mori gene to
encode an RNA methyltransferase geneusing the BLAST
software available on the NCBI web site.
The evolutionary relationships of a protein can provide
important information about its functions. Therefore, we
performed a phylogenetic tree analysis of RNA MTases
to identify homologs of BmRNAMTase in other species
(Figure 2). The phylogenetic tree shows the evolutionary
relationships of the structural domains of RNA MTases from
various species. It contains two primary branches: I and
II. Branch I is primarily composed of vertebrate homologs,
and branch II includes only invertebrate homologs. The
vertebrate homologs are more highly evolutionary conserved4 Comparative and Functional Genomics
than the invertebrate homologs. Therefore, we presumed
that the functional domains in RNA MTases changed signif-
icantly during the evolutionary split between invertebrates
and vertebrates. The species that are most closely related
showed a high degree of homology in the structural domain
within the RNA MTases.
3.2. Cloning,Expression,and Purification
We cloned theBmRNAMTase ORF into the expression vector
pET-28a (+). We then transformedE. coli to the recombinant
plasmid, grew transformed cells in culture to the appropriate
density, and used IPTG to induce expression of an 18.1kd
recombinant protein containing a His-tag (data not shown).
We puriﬁed the recombinant protein using successive steps
of SP-Sepharose (G200) column chromatography followed
by metal-chelating aﬃnity chromatography on a column
containing Ni2+-SephadexTM G-25 Superﬁne. We obtained
a yield of approximately 4.0mg of puriﬁed protein from
a one liter E. coli culture. The purity of the recombinant
protein, as estimated by SDS-PAGE, was greater than 90%
(Figure 3).
3.3. Immunohistochemistry Analysis
ELISAs showed that the titer of the polyclonal antibody is
about 1 : 51,200, and Western blot analyses revealed that the
antibody is highly speciﬁc for BmRNAMTase. We also deter-
mined that BmRNAMTase is highly expressed in silkworm
pupae.However,Westernblotanalysesindicatedanapparent
molecular weight of about 20kd, which is 6kd greater
than the predicted molecular weight (Figure 4). To address
this inconsistency, we used http://au.expasy.org/prosite/ to
identify potential sites in the BmRNAMTase amino acid
sequence that might be posttranslationally modiﬁed. We
found that BmRNAMTase contains two potential sites for
Casein kinase II phosphorylation: 5–8 (TRPE) and 21–
24 (TVED); three potential sites for N-myristoylation: 40–
45 (GVDYST), 73–78 (GLRLNI), and 90–95 (GMATAV);
and two potential sites for Protein kinase C phosphory-
lation: 64–66 (SYK) and 69–71 (SSR). The amino acid
sequence of BmRNAMTase also contains several potential
glycosylation sites, which is consistent with predictions
made using . http://www.cbs.dtu.dk/services/NetNGlyc/. It
is possible that posttranslational modiﬁcations are respon-
sible for the increased apparent molecular weight of
BmRNAMTase.
3.4. BmRNAMTase isAbundantin
the Cytoplasm of Bm5 Cell
To determine the subcellular localization of BmRNAM-
Tase, we performed immonohistochemistry, using the anti-
BmRNAMTase polyclonal antibodies as the primary anti-
body and Cy3-conjugated goat antirabbit antibodies as
the secondary antibody, to locate BmRNAMTase in Bm5
cells. We observed immunostained cells under a Nikon
ECLIPSE TE2000-E confocal microscope and determined
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Figure 2: The phylogenetic tree for RNA MTases from various
species. The node is the bootstrap value of 1000 repeats; scale
represents the distance of descent.
18.1kDa
M 1234
Figure 3: SDS-PAGE analysis of BmRNAMTase. Lane 1, the control
of BL21 (pET-28a(+)) after induction with IPTG, Lane 2, BL21
(pET-28a(+)-BmRNAMTase) after induction with IPTG, Lane 3,
pooled fractions from the SP-Sepharose(G200) column, Lane 4,
pooled fractions from the His-Trap column; Lane M, protein
markers (TaKaRa). Position of the 18.1kd protein standard is
indicated.
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Figure 4: Western blot analysis of puriﬁed recombinant protein
and protein derived from silkworm pupae. Lane 1, BmRNAMTase
extracted from silkworm pupae; Lane 2, the puriﬁed recombinant
protein.Comparative and Functional Genomics 5
(1) (2) (3)
Figure 5: The subcellular localization of BmRNAMTase in Bm5 cells. 1, immunostaining with anti-BmRNAMTase antibodies; 2, image of
nuclei using the nucleic acid stain DAPI; 3, overlay of images 1 and 2.
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Figure6:CytoactivityandBmRNAMTasecontentinBm5cellsafter
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that BmRNAMTase is found mostly in the cytoplasm; it
is particularly enriched in the inboard of karyotheca, and
little BmRNAMTase is found in the karyon (Figure 5). The
localization of BmRNAMTase suggests that it may play a role
in posttranscriptional modiﬁcation of RNAs.
3.5. Effect of RNAi on Cell Growth
MTT experiments demonstrated that the optimal con-
centration of the BmRNAMTase dsRNA for use in RNAi
e x p e r i m e n t si s6 . 0μg/μl and that the optimal duration of the
interference is 72 hours (data not shown). We determined
cytoactivity by MTT and determined BmRNAMTase content
in the cell by ELISA after cells had been treated for 72 hours
(Figure 6).Wealsodetermined whetherthetreatedBm5cells
Genomic DNA
M 1234
4500bp
3000bp
2250bp
1500bp
1000bp
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500bp
250bp
Figure 7: Determination of the apoptotic morphology of the cell
with DNA ladder. M, 250bp DNA marker; Lane 1, control; Lane
2, sample interfered with only lipid; Lane 3, sample interfered with
only dsRNA; Lane 4, sample interfered with lipid and dsRNA.
had become apoptotic by examining chromosomal DNA for
the appearance of a characteristic DNA ladder (Figure 7).
We concluded that the activity and content of BmR-
NAMTase in the Bm5 cells decreased signiﬁcantly following
the RNAi treatment and that silencing the BmRNAMTase
gene resulted in increased cell death (Figure 6). However,
we did not observe the formation of a DNA ladder in
the chromosomal DNA, which is characteristic indicator of
apoptotic cells [13]. The appearance of the chromosomal
DNA in the RNAi-treated cells indicated that cell death did
increase during the treatment, however, it also demonstrated
that there was no signiﬁcant increase in apoptotic cell death
in the treated cells. The changes in the activity and content of
BmRNAMTase in the cells were possibly due to necrotic cell
death.6 Comparative and Functional Genomics
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Figure 8: Alignment of BmRNAMTase and another class of RNA methyltransferases. Asterisks show the conserved sequences of ribosomal
RNA methyltransferases; the conserved sequences of SpoU family proteins are boxed in BmRNAMTase sequences.
4.Discussion
In the present study, we discovered the ﬁrst BmRNAMTase
gene in a silkworm pupae cDNA library. We expressed a
recombinant fusion BmRNAMTase protein in the E. coli
BL21 (DE3) strain, puriﬁed the recombinant protein, and
used it to generate anti-BmRNAMTase polyconal antibod-
ies for use in determining the subcellular localization of
BmRNAMTase. Immunohistochemistry indicated that the
majority of BmRNAMTase is found in the cytoplasm of Bm5
cells. In addition, RNAi experiments indicated that silencing
BmRNAMTase results in increased cell death.
RNA MTases collectively form an enzyme superfamily
[14,15]thathasimportantbiologicalfunctions.Methylation
isacommonpost-transcriptional modiﬁcationofRNAs;this
modiﬁcation can mediate control of translational process-
ing. Prerequisites for RNA methylation are the availability
of AdoMet-dependent MTases, which contain a common
catalytic core and binding sites for the substrate, and both
AdoMet and the substrate that corresponds to the binding
site in the enzyme; binding sites vary slightly, depending on
the substrate. Several studies on the mechanism of AdoMet-
dependent MTase recognition of the substrate have been
completed [16].Recently,studieshavefocusedonidentifying
catalytic and functional domains as well as determining the
speciﬁcRNAsequencesrecognizedintargetedsubstrates[17,
18]. The catalytic characteristics of several RNA AdoMet-
dependent MTases have been investigated extensively, how-
ever,themechanismresponsibleforrecognitionofsubstrates
remains obscure.
In this study, we determined that inhibiting BmRNAM-
Tase activity by depleting its content through RNA interfer-
enceresultsinincreasedcelldeath(Figures6and7).Analysis
of the amino acid sequence revealed that the functions of
BmRNAMTase might be similar to those of other members
of the SpoU protein family. The key amino acid residues in
SpoU family proteins are: R41, S150, P143, E124, N35, and
S37 [7]. By comparing the BmRNAMTase sequence to those
of other RNA MTases using CLUSTALW we determined that
the key amino acid residues in BmRNAMTase may be R75,
S61, P79, E91, N88, and S86 and that a possible function for
BmRNAMTase is catalyzing the methylation of the 2 -OH at
guanosine 18 in tRNAs.
Subcellular localization of BmRNAMTase in Bombyx
mori by confocal immunoﬂuorescence microscopy indi-
cated that the protein is concentrated in the cytoplasm
(Figure 5), which diﬀers signiﬁcantly from the observed
subcellular distribution of FTSJ2, a novel human RNA
methyltransferase [19]. FTSJ2 shares signiﬁcant sequence
homology withFtsJ/RrmJ, an E.coli23SrRNAuridine-2 -O-
methyltransferase [20] and is primarily found in the nucle-
olus. BmRNAMTase shares signiﬁcant sequence homology
with SpoU family proteins, which primarily catalyze the
transfer of a methyl group from AdoMet to the 2 -OH
of guanosine 18 in tRNAs [21]. However, BmRNAMTase
and other classes of RNA methyltransferases show diﬀerentComparative and Functional Genomics 7
conserved sequences (Figure 8). The existence of diﬀering
conserved sequences in various classes of methylases is
probably necessary to form diﬀerent functional domains and
bindingsitesfortargetingandmodifyingdiﬀerentsubstrates.
Alternative conserved amino acid sequences might also con-
tribute to the diﬀerences in subcellular localization observed
for various methylases.
WehavestudiedthecharacteristicsofBmRNAMTaseand
established a foundation for further functional studies on
this enzyme. Western blot analyses have revealed an apparent
molecular weight for BmRNAMTase in a silkworm pupa that
is 6kd greater than the predicted molecular weight; deter-
mining the underlying reason for this discrepancy requires
further investigation. In addition, more study is necessary
to determine the catalytic domain and the mechanism of
substrate recognition of BmRNAMTase.
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